{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:09:31Z","timestamp":1789967371957,"version":"4.0.1"},"reference-count":37,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>A rare cause of hypocalcemia, autosomal dominant hypocalcemia type 1 (ADH1) arises from a gain-of-function variant of the calcium-sensing receptor gene (CASR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Three patients from 2 unrelated families, presenting with hypocalcemia and other biochemical parameters consistent with ADH1, were examined for variants in the CASR with the aim to functionally assess any variant detected to confirm the ADH1 diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Sanger sequencing of the coding region of the CASR from the 3 patients identified a single CASR variant that was generated by site-directed-mutagenesis in the CASR as a FLAG-tagged construct in the mammalian expression vector pcDNA3.1. The variant's expression in HEK293 cells (compared to FLAG-tagged wild-type [WT] receptor) was assessed by Western blot analysis and its activity measured following calcium dosing experiments using an IP-One enzyme-linked immunosorbent assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sequence analysis revealed the presence of a heterozygous missense variant in the CASR, an adenine to guanine transition at nucleotide 1256 causing an asparagine to serine substitution at amino acid 419 (N419S) in the CaSR\u2019s Venus flytrap domain in all 3 patients. The N419S variant showed a modest increase in expression compared to the WT receptor. Significantly, the IP-One assay demonstrated that the variant is constitutively active in the absence of Ca++ ions and that this gain-of-function is maintained at physiologically relevant Ca++ ion concentrations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The N419S CASR variant affecting 2 separate families is constitutively activating and therefore causative of ADH1. This is the first report of a constitutively active variant affecting the extracellular domain of the CaSR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/jendso\/bvag164","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T03:40:45Z","timestamp":1786333245000},"source":"Crossref","is-referenced-by-count":1,"title":["Functional assessment of a constitutively activating\n                    <i>CASR<\/i>\n                    variant causing autosomal dominant hypocalcemia"],"prefix":"10.1210","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9251-2107","authenticated-orcid":false,"given":"Bryan K","family":"Ward","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital , Nedlands, WA 6009 ,","place":["Australia"]},{"name":"Harry Perkins Institute of Medical Research, Centre for Medical Research, QEII Medical Centre, University of Western Australia , Nedlands, WA 6009 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9109-9864","authenticated-orcid":false,"given":"Bronwyn G A","family":"Stuckey","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital , Nedlands, WA 6009 ,","place":["Australia"]},{"name":"Keogh Institute for Medical Research , Nedlands, WA 6009 ,","place":["Australia"]},{"name":"Medical School, University of Western Australia , Nedlands, WA 6009 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1766-2612","authenticated-orcid":false,"given":"John P","family":"Walsh","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital , Nedlands, WA 6009 ,","place":["Australia"]},{"name":"Medical School, University of Western Australia , Nedlands, WA 6009 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7232-3891","authenticated-orcid":false,"given":"Arthur D","family":"Conigrave","sequence":"additional","affiliation":[{"name":"School of Life and Environmental Sciences, Charles Perkins Centre (D17), University of Sydney , Camperdown, NSW 2006 ,","place":["Australia"]},{"name":"Department of Endocrinology, Royal Prince Alfred Hospital , Camperdown, NSW 2050 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8413-561X","authenticated-orcid":false,"given":"Suzanne J","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital , Nedlands, WA 6009 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0357-1373","authenticated-orcid":false,"given":"Scott G","family":"Wilson","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital , Nedlands, WA 6009 ,","place":["Australia"]},{"name":"School of Biomedical Sciences, University of Western Australia , Nedlands, WA 6009 ,","place":["Australia"]},{"name":"Department of Twin Research and Genetic Epidemiology, King's College London , London SE1 7EH ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"2026083112213712000_bvag164-B1","volume-title":"UpToDate 2024","author":"Goltzman"},{"issue":"18","key":"2026083112213712000_bvag164-B2","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJMcp1800213","article-title":"Hypoparathyroidism","volume":"380","author":"Gafni","year":"2019","journal-title":"N Engl J Med"},{"issue":"6455","key":"2026083112213712000_bvag164-B3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","article-title":"Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid","volume":"366","author":"Brown","year":"1993","journal-title":"Nature"},{"issue":"21","key":"2026083112213712000_bvag164-B4","doi-asserted-by":"crossref","first-page":"12919","DOI":"10.1074\/jbc.270.21.12919","article-title":"Molecular-cloning and functional expression of human parathyroid calcium receptor cDNAs","volume":"270","author":"Garrett","year":"1995","journal-title":"J Biol Chem"},{"issue":"3","key":"2026083112213712000_bvag164-B5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ng1194-303","article-title":"Autosomal dominant hypocalcaemia caused by a Ca2+-sensing receptor gene mutation","volume":"8","author":"Pollak","year":"1994","journal-title":"Nat Genet"},{"issue":"6","key":"2026083112213712000_bvag164-B6","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.ajhg.2020.04.006","article-title":"Familial hypocalciuric hypercalcemia type 1 and autosomal-dominant hypocalcemia type 1: prevalence in a large healthcare population","volume":"106","author":"Dersham","year":"2020","journal-title":"Am J Human Genet"},{"issue":"8","key":"2026083112213712000_bvag164-B7","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.ajhg.2025.06.013","article-title":"A calcium-sensing receptor allelic series and underdiagnosis of genetically driven hypocalcemia","volume":"112","author":"Chang","year":"2025","journal-title":"Am J Human Genet"},{"issue":"26","key":"2026083112213712000_bvag164-B8","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit alpha 11 in hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"2026083112213712000_bvag164-B9","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1530\/JME-16-0124","article-title":"Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis","volume":"57","author":"Hannan","year":"2016","journal-title":"J Mol Endocrinol"},{"issue":"7","key":"2026083112213712000_bvag164-B10","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0092-8674(93)90617-Y","article-title":"Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism","volume":"75","author":"Pollak","year":"1993","journal-title":"Cell"},{"issue":"1","key":"2026083112213712000_bvag164-B11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1172\/JCI119137","article-title":"In Vivo and In Vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia","volume":"99","author":"Bai","year":"1997","journal-title":"J Clin Invest"},{"issue":"2","key":"2026083112213712000_bvag164-B12","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JME-19-0104","article-title":"Molecular and clinical insights from studies of calcium-sensing receptor mutations","volume":"63","author":"Gorvin","year":"2019","journal-title":"J Mol Endocrinol"},{"issue":"10","key":"2026083112213712000_bvag164-B13","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/jbmr.4659","article-title":"Autosomal dominant hypocalcemia type 1: a systematic review","volume":"37","author":"Roszko","year":"2022","journal-title":"J Bone Min Res"},{"issue":"5","key":"2026083112213712000_bvag164-B14","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvac042","article-title":"Autosomal dominant hypocalcemia type 1 (ADH1) associated with myoclonus and intracerebral calcifications","volume":"6","author":"Elston","year":"2022","journal-title":"J Endocrine Soc"},{"issue":"6","key":"2026083112213712000_bvag164-B15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000303188","article-title":"Phenotypic variation in a large family with autosomal dominant hypocalcaemia","volume":"74","author":"Sorheim","year":"2010","journal-title":"Horm Res Paediatrics"},{"issue":"9","key":"2026083112213712000_bvag164-B16","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/jbmr.3747","article-title":"Treatment of autosomal dominant hypocalcemia type 1 with the calcilytic NPSP795 (SHP635)","volume":"34","author":"Scott Roberts","year":"2019","journal-title":"J Bone Min Res"},{"key":"2026083112213712000_bvag164-B17","volume-title":"UpToDate 2025","author":"Goltzman"},{"issue":"2","key":"2026083112213712000_bvag164-B18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1210\/clinem\/dgae769","article-title":"CASRdb: a publicly accessible comprehensive database for disease-associated calcium-sensing receptor variants","volume":"110","author":"Charoenngam","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026083112213712000_bvag164-B19","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/B978-0-443-13683-2.00045-1","volume-title":"Genetics of Bone Biology and Skeletal Disease","author":"Conigrave","year":"2026","edition":"3rd ed"},{"issue":"5","key":"2026083112213712000_bvag164-B20","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvac025","article-title":"Functional assessment of calcium-sensing receptor variants confirms familial hypocalciuric hypercalcemia","volume":"6","author":"Mullin","year":"2022","journal-title":"J Endocrine Soc"},{"issue":"5","key":"2026083112213712000_bvag164-B21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Medicine"},{"issue":"9","key":"2026083112213712000_bvag164-B22","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1210\/jc.2012-1429","article-title":"The importance of measuring ionized calcium in characterizing calcium status and diagnosing primary hyperparathyroidism","volume":"97","author":"Ong","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026083112213712000_bvag164-B23","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00223-020-00715-1","article-title":"Functional analysis of calcium-sensing receptor variants identified in families provisionally diagnosed with familial hypocalciuric hypercalcaemia","volume":"107","author":"Magno","year":"2020","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"2026083112213712000_bvag164-B24","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-2265.2006.02512.x","article-title":"Novel mutations in the calcium-sensing receptor gene associated with biochemical and functional differences in familial hypocalciuric hypercalcaemia","volume":"64","author":"Ward","year":"2006","journal-title":"Clin Endocrinol"},{"issue":"16","key":"2026083112213712000_bvag164-B25","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2026083112213712000_bvag164-B26","doi-asserted-by":"crossref","first-page":"D884","DOI":"10.1093\/nar\/gkaa942","article-title":"Ensembl 2021","volume":"49","author":"Howe","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"2026083112213712000_bvag164-B27","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/hmg\/dds105","article-title":"Identification of 70 calcium sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites","volume":"21","author":"Hannan","year":"2012","journal-title":"Hum Mol Genet"},{"key":"2026083112213712000_bvag164-B28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-1-4939-0956-8_8","article-title":"G protein-coupled receptor mutations and human disease","volume":"1175","author":"Thompson","year":"2014","journal-title":"Method Mol Biol"},{"key":"2026083112213712000_bvag164-B29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1877-1173(09)89003-0","article-title":"Calcium-sensing receptor and associated diseases","volume":"89","author":"Hendy","year":"2009","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"4","key":"2026083112213712000_bvag164-B30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/1098-2779(2000)6:4<253::AID-MRDD4>3.0.CO;2-P","article-title":"Developmental seizures induced by common early-life insults: short- and long-term effects on seizure susceptibility","volume":"6","author":"Jensen","year":"2000","journal-title":"Ment Retard Dev Disibil Res Rev"},{"issue":"1","key":"2026083112213712000_bvag164-B31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0014-5793(99)00368-3","article-title":"A missense mutation in the seventh transmembrane domain constitutively activates the human Ca2+ receptor","volume":"448","author":"Zhao","year":"1999","journal-title":"FEBS Lett"},{"key":"2026083112213712000_bvag164-B32","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1215036","article-title":"Case report: calcium sensing receptor gene gain of function mutations: a case series and report of 2 novel mutations","volume":"14","author":"Ali","year":"2023","journal-title":"Front Endocrinol"},{"issue":"6","key":"2026083112213712000_bvag164-B33","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1074\/jbc.M413403200","article-title":"A region in the seven-transmembrane domain of the human Ca2+ receptor critical for response to Ca2+","volume":"280","author":"Hu","year":"2005","journal-title":"J Biol Chem"},{"key":"2026083112213712000_bvag164-B34","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2018.00200","article-title":"Identification and functional characterization of a novel mutation in the human calcium-sensing receptor that co-segregates with autosomal-dominant hypocalcemia","volume":"9","author":"Rasmussen","year":"2018","journal-title":"Front Endocrinol"},{"key":"2026083112213712000_bvag164-B35","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.13662","article-title":"Structural mechanism of ligand activation in human calcium-sensing receptor","volume":"5","author":"Geng","year":"2016","journal-title":"eLife"},{"issue":"5","key":"2026083112213712000_bvag164-B36","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/cen.12056","article-title":"Identification and characterization of D410E, a novel mutation in the loop 3 domain of CASR, in autosomal dominant hypocalcemia and a therapeutic approach using a novel calcilytic, AXT914","volume":"78","author":"Park","year":"2013","journal-title":"Clin Endocrinol"},{"issue":"1","key":"2026083112213712000_bvag164-B37","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-024-06189-3","article-title":"Absence of calcium-sensing receptor basal activity due to inter-subunit disulfide bridges","volume":"7","author":"Ma","year":"2024","journal-title":"Commun Biol"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvag164\/70581375\/bvag164.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/9\/bvag164\/70581375\/bvag164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/9\/bvag164\/70581375\/bvag164.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:21:49Z","timestamp":1788193309000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvag164\/8757721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvag164","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,1]]},"article-number":"bvag164"}}